Hedge Fund and Insider Trading News: Mike Novogratz, David Einhorn, Soros Fund Management, Jana Partners, Coatue Management, Brummer & Partners, Valeo Pharma Inc (VPHIF), Alphabet Inc (GOOG), and More

Page 2 of 2

Hedge Fund Legend David Einhorn Warns Investors aren’t Doing their Homework, Predicts Stubborn Inflation, and Says Crypto is Too Complex for Him in a New Interview. Here are the 10 Best Quotes. (Business Insider)
Hedge fund manager David Einhorn cautioned that not every loss-making startup will be the next Amazon, complained that too few investors are scrutinizing company accounts, and predicted stubborn inflation in a RealVision interview this week. The Greenlight Capital boss also bemoaned the trend of people investing based on market sentiment instead of fundamentals, and said cryptocurrencies are too complex and uncertain for him to trade them.

A Contemporary Evaluation of Key Alternative Investments (Hedge Nordic)
By Dan Rizzuto, CFA and Linus Nilsson, CFA: Our article offers a condensed version of a contemporary evaluation of alternative investments represented by CTAs, Risk Premia, and Hedge Funds we recently completed. Here we describe Risk Premia as passive/semi-passive investments in alternative strategies and we have contrasted these investments with the active management approach of CTAs and Hedge Funds. In particular, we note an interesting correlation drift, that may not line up with expected risk and performance characteristics.

Thursday 10/7 Insider Buying Report: RMCF, JUPW (Nasdaq.com)
At Rocky Mountain Chocolate Factory, a filing with the SEC revealed that on Wednesday, Bradley Louis Radoff bought 18,183 shares of RMCF, for a cost of $7.22 each, for a total investment of $131,354. Radoff was up about 7.8% on the buy at the high point of today’s trading session, with RMCF trading as high as $7.79 in trading on Thursday. Rocky Mountain Chocolate Factory is trading off about 0.7% on the day Thursday. Before this latest buy, Radoff purchased RMCF at 4 other times during the past year, for a total investment of $783,268 at an average of $7.98 per share. And at Jupiter Wellness, there was insider buying on Wednesday, by CEO Brian John who bought 51,556 shares at a cost of $1.42 each, for a total investment of $73,023. Jupiter Wellness is trading up about 13.1% on the day Thursday. So far John is in the green, up about 18.6% on their purchase based on today’s trading high of $1.68.

The Chairman of Valeo Pharma (Other OTC: VPHIF) is Buying Shares (Analyst Ratings)
Yesterday, the Chairman of Valeo Pharma (VPHIF), Richard J Mackay, bought shares of VPHIF for $75K. In addition to Richard J Mackay, 4 other VPHIF executives reported Buy trades in the last month. This recent transaction increases Richard J Mackay’s holding in the company by 1% to a total of $6.04 million. Based on Valeo Pharma’s latest earnings report for the quarter ending July 31, the company posted quarterly revenue of $5.67 million and GAAP net loss of -$2,969,000.

Alphabet Insider Sold $8.1M In Company Stock (Benzinga)
Sundar Pichai, Chief Executive Officer at Alphabet (NASDAQ:GOOG), made a large insider sell on October 6, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Pichai sold 3,000 shares of Alphabet at prices ranging from $2,694 to $2,721. The total transaction amounted to $8,127,904. Pichai still owns a total of 88,693 shares of Alphabet worth, $247,310,674.

Page 2 of 2